Range Products Brings Black Seed Oil Products to Health-Conscious Australian Consumers

OneMetric Selected by HubSpot to Present Agentic Solution at UNBOUND 2026

PrimeSpace Capital Created a High-Performing Management Company. They Built it On QuikStor

PsychAssist.ai Launches The First Clinical Reasoning Engine for AI Psychological Assessment and Report Writing

IC Optimize Announces Odin and Joins the Cadence Connections Program

Warehouse Robotics Market: A Building-Shaped Commitment With A Twenty-Year Payback

Holtec Nuclear Corporation Announces Launch of Initial Public Offering

AVEX INVESTOR DEADLINE: AEVEX Corp. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - October 20,...

Modern Micro Endodontics Opens Ninth New Jersey Location in Englewood Cliffs

Ascletis Announces Initiation of Phase I Study in U.S. for Oral Amylin Receptor Peptide Agonist ASC36 for the Treatment of Obesity

INV Lawsuit Alert: Innventure Investors Face October 27 Deadline After 55% Stock Drop Tied to Data Center Deal Cancellation

UWMC Lawsuit Alert: UWM Holdings Investors Face October 13 Deadline After 34% Stock Drop Tied to Hedging Strategy Issues

YSS Lawsuit Alert: York Space Systems Investors Face October 30 Deadline After 10% Stock Drop Tied to Satellite Software Issues

CAPR Lawsuit Alert: Capricor Therapeutics Investors Face September 28 Deadline After 64% Stock Drop Tied to Clinical Data Disclosure

CCB Investigation Alert: Coastal Financial Faces Securities Fraud Investigation After 43% Stock Drop Tied to Banking Services Issues

CDNL Investigation Alert: Cardinal Infrastructure Faces Securities Fraud Investigation After 36% Stock Drop Tied to Acquisition Issues

DKS Investigation Alert: Dick's Sporting Goods Faces Securities Fraud Investigation After 30% Stock Drop Tied to Inventory Issues

GDDY Lawsuit Alert: GoDaddy Investors Face October 26 Deadline After 14% Stock Drop Tied to Customer Acquisition Issue

RXT Lawsuit Alert: Rackspace Technology Investors Face September 28 Deadline After 33% Stock Drop Tied to AI Effort Issues

PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete...